These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 23306701

  • 21. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C, Chen B, Jiao A, Li F, Sun N, Zhang G, Zhang J.
    BMC Cancer; 2018 Nov 28; 18(1):1179. PubMed ID: 30486878
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
    Cheng J, Wu LM, Deng XS, Wu J, Lv Z, Zhao HF, Yang Z, Ni Y.
    Hepatobiliary Pancreat Dis Int; 2018 Aug 28; 17(4):336-344. PubMed ID: 30108016
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 24. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J, Liu L, Zou H, Yu W.
    Yonsei Med J; 2019 Oct 12; 60(10):905-913. PubMed ID: 31538425
    [Abstract] [Full Text] [Related]

  • 25. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 12; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 26. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q, Yang X, Zhou X, Wu B, Zhu D, Jia W, Chu J, Wang J, Wu J, Kong L.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):889-897. PubMed ID: 32279994
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
    Zhuang L, Wang X, Wang Z, Ma X, Han B, Zou H, Wu Z, Dong S, Qu Z, Zang Y, Wu L.
    Cell Death Dis; 2017 May 18; 8(5):e2804. PubMed ID: 28518144
    [Abstract] [Full Text] [Related]

  • 28. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X, Liu L, Zou H, Zheng YW, Wang KP.
    Dig Liver Dis; 2019 Oct 18; 51(10):1446-1455. PubMed ID: 31147216
    [Abstract] [Full Text] [Related]

  • 29. PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.
    Liu T, Zu CH, Wang SS, Song HL, Wang ZL, Xu XN, Liu HS, Wang YL, Shen ZY.
    Oncotarget; 2016 Jul 12; 7(28):43376-43389. PubMed ID: 27270320
    [Abstract] [Full Text] [Related]

  • 30. Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p.
    Wang ZY, Zhu Z, Wang HF, Qin B, Liu J, Yao XH, Li WC, Chen KS.
    J Cell Physiol; 2019 Aug 12; 234(10):17775-17785. PubMed ID: 30864145
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J.
    Cancer Lett; 2013 Sep 01; 337(2):226-36. PubMed ID: 23684551
    [Abstract] [Full Text] [Related]

  • 32. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
    Kim JE, Hwang MH, Lee HW, Lee SW, Lee J, Ahn BC.
    Nucl Med Biol; 2013 Nov 01; 40(8):987-93. PubMed ID: 24054501
    [Abstract] [Full Text] [Related]

  • 33. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
    Wang W, Zhang H, Wang L, Zhang S, Tang M.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):987-992. PubMed ID: 27049311
    [Abstract] [Full Text] [Related]

  • 34. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W.
    J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144
    [Abstract] [Full Text] [Related]

  • 35. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug 29; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 36. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y.
    J Exp Clin Cancer Res; 2019 Jan 08; 38(1):7. PubMed ID: 30621734
    [Abstract] [Full Text] [Related]

  • 37. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX.
    Int J Clin Exp Pathol; 2014 Jan 08; 7(7):4039-44. PubMed ID: 25120782
    [Abstract] [Full Text] [Related]

  • 38. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    J Cell Biochem; 2021 Jan 08; 122(1):86-99. PubMed ID: 32786108
    [Abstract] [Full Text] [Related]

  • 39. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.
    Oncotarget; 2015 Dec 08; 6(39):42040-52. PubMed ID: 26547929
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X, Li L, Wang J, Xu Q, Yang L, Huang D.
    J Cell Mol Med; 2019 Aug 08; 23(8):5037-5047. PubMed ID: 31207037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.